Home » Biopharmaceutical and Biomedicine Market

Biopharmaceutical and Biomedicine Market By Biopharmaceutical Product Types (Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Gene and Cell Therapies, Nucleic Acid Therapeutics, Viral Vector-Based Therapies, Biosimilars, Blood and Blood Component Products, Biopharmaceutical Contract Manufacturing) By Therapeutic Areas (Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Diseases, Rare Diseases (Orphan Drugs), Cardiovascular Diseases, Gastrointestinal Disorders, Hematology, Dermatology) By Biopharmaceutical Companies (Pharmaceutical Companies, Biotechnology Startups, Contract Research Organizations (CROs), Academic and Research Institutions) By Regulatory and Compliance, Regulatory Agencies, Good Manufacturing Practices (GMP), Clinical Trials, Pharmacovigilance) By Market Trends (Personalized Medicine, Biopharmaceutical Innovation, Biosimilars and Biogenerics, Cell and Gene Therapies, Immunotherapy) By Region – Growth, Share, Opportunities & Competitive Analysis, 2022-2030

Price: $4999

Published: | Report ID: 31052 | Report Format : PDF

Market Insights

  • The global demand for biopharmaceutical and biomedicine was valued at USD 545848.5 million in 2022 and is expected to reach USD 1153163.37 million in 2030, growing at a CAGR of 9.80% between 2023 and 2030.
  • Gene and cell therapies are the leading segment of biopharmaceutical product types. On the other hand, biosimilars are expected to grow at a strong CAGR.
  • The leading therapeutic area segment is oncology.
  • The CAGR for the pharmaceutical companies is expected to be the highest during the projection period.
  • During the forecast time frame, the clinical trials category will likely have the highest CAGR.
  • During the forecast period, biopharmaceutical innovations are estimated to have the greatest CAGR.
  • In 2022, the North American region dominated the biopharmaceutical and biomedicine market.
  • Europe is predicted to be the second-largest region in the biopharmaceutical and biomedicine market.
  • Asia Pacific is anticipated to grow at the fastest rate in the biopharmaceutical and biomedicine market.
  • The industry is expanding due to the demand for biopharmaceutical and biomedicine, an expansion of the rising demand for personalized medicine, and increasing healthcare spending.
  • The biopharmaceutical and biomedicine market has a lot of potential growth prospects due to factors like growing neurodegenerative disease research, nanotechnology in drug delivery, artificial intelligence in drug discovery, and 3D bioprinting.

Biopharmaceutical and Biomedicine Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Executive Summary

Market Definition

The biopharmaceutical and biomedicine market encompasses the development, production, and commercialization of pharmaceutical products derived from biological sources. It includes biotechnological advancements, gene therapies, and innovative medical treatments that leverage biological systems. This dynamic market plays a crucial role in addressing complex diseases by harnessing the power of biological processes for therapeutic interventions. It involves a multidisciplinary approach, combining biology, medicine, and technology to advance healthcare solutions.

Market Overview

The market for biopharmaceutical and biomedicine has been expanding steadily in recent years, and between 2023 and 2030, it is anticipated to rise at a CAGR of 9.80%. The market was estimated to be worth USD 545848.5 million in 2022 and is expected to be worth USD 1153163.37 million in 2030.

Preventive healthcare emphasizes early intervention and the identification of potential health risks before the onset of symptoms. Biopharmaceuticals play a crucial role in early diagnosis and treatment. Increased awareness prompts individuals to undergo regular screenings and diagnostic tests. Biopharmaceuticals contribute to the development of advanced diagnostic tools and precision medicine for targeted treatments based on individual health profiles.

The prevalence of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, increases with age. Biopharmaceuticals play a crucial role in developing treatments that slow disease progression and improve quality of life. The aging population benefits from personalized medicine approaches that consider individual health profiles, genetics, and comorbidities. Biopharmaceuticals play a key role in tailoring treatments to the specific needs of geriatric patients.

The growth of personalized medicine is closely tied to the development of companion diagnostics. These tests help identify patients who are most likely to benefit from specific biopharmaceutical treatments. The demand for personalized medicine aligns with a patient-centric approach to drug development. Biopharmaceutical companies are increasingly focused on developing treatments that address individual patient needs.

Segmentation by Biopharmaceutical Product Types

  • By biopharmaceutical product types, gene and cell therapies are the market leader. This is because treatments involving genes and cells play a critical role in treating rare diseases caused by a single genetic mutation. These therapies provide potential treatments or significant improvements in quality of life.
  • The biosimilars category is anticipated to exhibit a sizable CAGR during the projected period. Biosimilars are utilized in the treatment of chronic diseases such as rheumatoid arthritis, inflammatory bowel diseases, and various forms of cancer, offering effective and more affordable alternatives.
  • Other biopharmaceutical product types, such as monoclonal antibodies (mAbs), vaccines, recombinant proteins, nucleic acid therapeutics, viral vector-based therapies, blood and blood component products, biopharmaceutical contract manufacturing, also contribute to the demand for biopharmaceutical and biomedicine.

Segmentation by Therapeutic Areas

  • The main therapeutic area category is oncology. Precision medicine in oncology involves tailoring treatments based on the individual characteristics of a patient’s cancer. Biopharmaceuticals play a crucial role in developing targeted therapies that aim to be more effective and less toxic than traditional treatments.
  • The autoimmune diseases category will likely register a significant CAGR during forecasting. Monoclonal antibodies and other biologics play a crucial role in autoimmune disease treatment by targeting specific immune cells, cytokines, or pathways involved in the autoimmune process.
  • Other therapeutic areas, such as infectious diseases, neurodegenerative diseases, rare diseases (orphan drugs), cardiovascular diseases, gastrointestinal disorders, hematology, and dermatology, also contribute to the demand for biopharmaceutical and biomedicine.

Segmentation by Biopharmaceutical Companies

  • The category for pharmaceutical companies is anticipated to experience the highest CAGR during the projection period. The demand for high-quality APIs for biopharmaceuticals, such as monoclonal antibodies, vaccines, and gene therapies, is significant. Pharmaceutical companies seek reliable suppliers of APIs to ensure the quality and efficacy of their final products.
  • Other biopharmaceutical companies, such as biotechnology startups, contract research organizations (CROs), and academic and research institutions, also contribute to the demand for biopharmaceutical and biomedicine.

Segmentation by Regulatory and Compliance

  • The clinical trials category will likely have the highest CAGR during the projection period. Clinical trials are increasingly being conducted on a global scale to ensure diverse patient populations are represented. This globalization requires the coordination of multi-site trials, contributing to the demand for clinical trial services.
  • Other regulatory and compliance, such as regulatory agencies, good manufacturing practices (GMP), and pharmacovigilance, also contribute to the demand for biopharmaceutical and biomedicine.

Segmentation by Market Trends

  • The biopharmaceutical innovation category will be expected to have the foremost CAGR during the prediction period. Innovations in drug delivery systems, such as nanoparticles, liposomes, and implantable devices, enhance the efficacy, safety, and convenience of biopharmaceutical administration, meeting patient and healthcare provider preferences.
  • Other market trends, such as personalized medicine, biosimilars and biogenerics, cell and gene therapies, and immunotherapy, also contribute to the demand for biopharmaceutical and biomedicine.

Segmentation by Region

  • North America leads the biopharmaceutical and biomedicine industry. The regulatory framework in North America, including the United States Food and Drug Administration (FDA) and Health Canada, provides clear guidelines and processes for the approval of biopharmaceutical products, fostering industry growth.
  • Europe is estimated to rank second in market size for biopharmaceutical and biomedicine.
  • Asia Pacific will witness the most rapid growth in the biopharmaceutical and biomedicine market.
  • The rest of the world, including Latin America, the Middle East, and Africa, meets the rest of the biopharmaceutical and biomedicine demand.

Biopharmaceutical and Biomedicine Market Research

The growing demand for minimally invasive procedures, expansion of biopharmaceutical manufacturing capacity, growing demand for contract research organizations (CROs), and rising need for companion diagnostics are all contributing factors to the increased demand for the biopharmaceutical and biomedicine market.

During forecasting, North America will probably rule the biopharmaceutical and biomedicine market. North America boasts highly developed and advanced healthcare infrastructure, providing a conducive environment for the research, development, and commercialization of biopharmaceuticals and biomedicine. The region’s large and aging population, coupled with a high prevalence of chronic diseases, contributes to the strong demand for advanced biopharmaceutical solutions, driving market growth.

The Asia Pacific area is projected to grow fastest throughout the forecast. Asia Pacific is home to some of the world’s fastest-growing economies, leading to increased healthcare spending and a rising demand for advanced biopharmaceutical solutions. The region is experiencing a rise in clinical trial activity, with multinational pharmaceutical companies conducting trials in Asia Pacific countries to assess the safety and efficacy of biopharmaceutical products.

Higher disposable incomes may lead to a greater demand for innovative and cutting-edge treatments. Biopharmaceuticals, being at the forefront of medical innovation, can benefit from this increased demand. Rising disposable incomes may contribute to increased interest and investment in regenerative medicine, an area within the biopharmaceutical sector focused on tissue repair and regeneration.

The integration of digital health enables remote monitoring of patients, especially those undergoing biopharmaceutical treatments. Continuous monitoring enhances patient care, improves adherence, and provides valuable real-time data for healthcare providers. Digital therapeutics, often used in conjunction with biopharmaceuticals, involve the use of software applications to deliver evidence-based interventions for the treatment or management of medical conditions. This integration provides holistic treatment solutions.

Key Highlights of the Report

The global biopharmaceutical and biomedicine market is segmented by biopharmaceutical product types, therapeutic areas, biopharmaceutical companies, regulatory and compliance, market trends, and region. As far as the biopharmaceutical product types are concerned, gene and cell therapies are the market spearhead. Oncology is the top therapeutic area segment. The pharmaceutical companies are expected to grow at the highest CAGR during the forecast period. The clinical trials are anticipated to experience the highest CAGR during the forecast period. North America is driving the growth of the biopharmaceutical and biomedicine market.

The biopharmaceutical and biomedicine market is growing as a result of significant technological advancements. High-throughput genomic sequencing and gene-editing technologies, such as CRISPR-Cas9, enable a deeper understanding of genetic factors, facilitating the development of targeted and personalized biopharmaceuticals. NGS technologies allow for faster and more cost-effective sequencing of DNA and RNA, aiding in genomic research and biomarker discovery for biopharmaceutical development. Advanced omics technologies provide insights into the complex interactions of proteins, metabolites, and other molecular entities, contributing to a comprehensive understanding of diseases and the development of biopharmaceutical interventions.

However, according to forecasts, North America will hold the largest market share for biopharmaceutical and biomedicine globally. North America has been adopting biosimilars, contributing to increased competition and expanding the market for biopharmaceuticals. Efficient and well-established distribution networks in North America ensure timely and widespread access to biopharmaceutical products across the region. Additionally, the Asia Pacific region is assumed to have the sharpest growth in the market. Asia Pacific has witnessed a surge in biotechnology research and development, with a growing number of biotech firms contributing to advancements in biopharmaceuticals.

Which Key Factors Are Driving The Global Biopharmaceutical and Biomedicine Market?

The industry for biopharmaceutical and biomedicine is fostered due to the rising prevalence of chronic diseases, the growing aging population, increasing technological advancements, and growing awareness of preventive healthcare.

What Are The Key Challenges In The Global Market For Biopharmaceutical and Biomedicine?

The high development costs, stringent regulatory requirements, market access challenges, limited patent protection, and complex manufacturing processes hinder the market’s growth for biopharmaceutical and biomedicine.

What Market Opportunities Exist For Biopharmaceutical and Biomedicine Globally?

Biopharmaceutical and biomedicine have a lot of opportunities to grow because of the growing advancements in precision medicine, increasing need for gene and cell therapies, rising demand for biosimilars, and immunotherapy expansion.

Market Drivers

Several factors influence the global market for biopharmaceutical and biomedicine. The main factors influencing the market for biopharmaceutical and biomedicine globally are as follows:

Rising Incidence of Chronic Diseases

The market for biopharmaceuticals and biomedicine is growing as a result of the increased prevalence of chronic diseases. The global prevalence of chronic diseases such as diabetes, cardiovascular disorders, and various forms of cancer is on the rise. This growing patient population requires innovative and effective treatment options. As the global population ages, there is a higher likelihood of individuals developing chronic conditions associated with aging, leading to an increased demand for therapies that address age-related diseases. Changing lifestyles, including sedentary behavior, unhealthy diets, and increased stress, contribute to the rising incidence of chronic diseases. Biopharmaceuticals provide targeted and often more effective treatment options for these complex conditions. Genetic factors play a role in the susceptibility to certain chronic diseases. Advances in genetic research and personalized medicine allow for the development of biopharmaceuticals tailored to individuals based on their genetic profiles.

Market Restraints

Several challenges could prevent the expansion of the global market for biopharmaceutical and biomedicine. Among them are the following:

High Development Costs

The high development costs associated with the research, development, and commercialization of biopharmaceuticals represent a significant restraining factor for the biopharmaceutical and biomedicine market. Early-stage research and preclinical studies require substantial investments in laboratory work, animal testing, and data analysis, contributing significantly to the overall development costs. Conducting extensive and rigorous clinical trials, including Phase I, II, and III trials, involves substantial costs for patient recruitment, monitoring, data management, and regulatory compliance. Meeting the stringent regulatory requirements imposed by health authorities increases development costs. Ensuring compliance with evolving regulations adds complexity and expense to the development process. The adoption of advanced technologies, such as sophisticated analytical tools and state-of-the-art manufacturing facilities, requires substantial upfront investments, contributing to the overall development costs.

Opportunities

The global market for biopharmaceutical and biomedicine presents significant potential opportunities. The following is an example of these:

Rising Gene and Cell Therapies

Gene and cell therapies are expected to create opportunities for the growth of the biopharmaceutical and biomedicine market. Gene therapies offer targeted interventions for genetic disorders by introducing, repairing, or replacing defective genes. This approach holds promise for conditions with a known genetic basis. Gene and cell therapies contribute to the advancement of personalized medicine, tailoring treatments based on individual genetic profiles for enhanced efficacy and reduced side effects. Cell therapies, such as CAR-T cell therapy, have shown remarkable success in treating certain cancers by modifying patients’ immune cells to target and destroy cancer cells. Hematopoietic stem cell transplantation, a form of cell therapy, is widely used in treating hematological disorders such as leukemia and certain genetic blood disorders. Gene therapies are expanding their applications in oncology, not only for treatment but also for diagnostics and monitoring, contributing to a comprehensive approach to cancer care.

Competitive Landscape

Biopharmaceutical and Biomedicine Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global market for biopharmaceutical and biomedicine is very competitive, with many powerful players. Some of the leading market participants and their corresponding market shares are listed below:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Takara Bio
  • Agilent Technologies
  • Oxford Expression Technologies
  • Promega Corporation
  • Qiagen N.V.
  • Bio-Rad Laboratories
  • New England Biolabs
  • Genscript Biotech Corporation
  • Syngene International Limited
  • Sartorius AG
  • Aragen Bioscience
  • Vivopure
  • Creative Biogene
  • Absolute Antibody
  • Rockland Immunochemicals
  • Protein Technologies Inc.
  • Proteogenix
  • Virovek
  • Others

To stay competitive, these businesses prioritize producing new products, growing their distribution network, and engaging in mergers and acquisitions.

The leading competitors in the global biopharmaceutical and biomedicine market are constantly looking for ways to get an advantage by releasing new items and advancements.

In August 2022, Amgen acquired ChemoCentryx, Inc. for USD 52 in cash per share, or an estimated USD 3.7 billion in enterprise value, with the goal of treating autoimmune, inflammatory, and cancerous disorders.

In May 2022, JSR Life Sciences, a provider of research products and services for external drug discovery and development, announced the launch of Similis Bio. This new business division will act as a partnering division to collaborate with biopharmaceutical companies to lower costs and increase efficiency in the biosimilar development process.

Summary of Key Findings

  • The biopharmaceutical and biomedicine industry has continued to grow due to the rising incidence of chronic illnesses.
  • The market is segmented by biopharmaceutical product types, therapeutic areas, biopharmaceutical companies, regulatory and compliance, market trends, and region.
  • Gene and cell therapies are seeing an increase in market share.
  • The most ubiquitous therapeutic area fragment is oncology.
  • Regarding CAGR, pharmaceutical companies are expected to grow fastest during the forecast period.
  • The category for clinical trials will likely see the highest CAGR during the anticipated time frame.
  • North America is leading market development; the market is highly competitive with key players including Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek, and others.

Future Outlook

  • Optimistic viewpoint for the global biopharmaceutical and biomedicine market with noteworthy growth potential in the North American region.
  • Increasing demand for personalized medicine is a key factor propelling the biopharmaceutical and biomedicine market.
  • During the projected period, the high development costs might significantly challenge the market’s expansion.
  • Foremost companies must concentrate on product innovation, expanding their market reach, and maintaining competitive pricing to stay ahead.

How CXOs Can Benefit from the Credence Research Biopharmaceutical and Biomedicine Market Report

The Credence Research Biopharmaceutical and Biomedicine Market Report provide CXOs with a comprehensive overview of the market, including:

  • Market size and growth forecast: The report provides detailed estimates of the global biopharmaceutical and biomedicine market size, segmented by biopharmaceutical product types, therapeutic areas, biopharmaceutical companies, regulatory and compliance, market trends, and region. It also includes forecasts for the market through 2032 based on key trends and drivers.
  • Market segmentation: The report segments the biopharmaceutical and biomedicine market by biopharmaceutical product types, therapeutic areas, biopharmaceutical companies, regulatory and compliance, market trends, and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
  • Competitive landscape: The report profiles the key players in the biopharmaceutical and biomedicine market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
  • Key trends and drivers: The report identifies and analyzes the key trends and drivers that are shaping the biopharmaceutical and biomedicine market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Biopharmaceutical and Biomedicine Market Report to:

  • Identify growth opportunities: The report can help CXOs identify new growth opportunities in the biopharmaceutical and biomedicine market. For example, the report identifies the rising demand for biopharmaceutical and biomedicine from hospitals and healthcare institutions, clinics and specialty centers, and government healthcare agencies as a key opportunity.
  • Make informed investment decisions: The report can help CXOs make informed investment decisions about biopharmaceutical and biomedicine. For example, the report provides insights into the key factors to consider when evaluating biopharmaceutical and biomedicine providers and selecting biopharmaceutical and biomedicine solutions.
  • Develop competitive strategies: The report can help CXOs develop competitive strategies for their biopharmaceutical and biomedicine businesses. For example, the report identifies the key strategies that biopharmaceutical and biomedicine providers are using to differentiate themselves from their competitors.
  • Track market developments: The report can help CXOs track market developments and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the biopharmaceutical and biomedicine market.

Overall, the Credence Research Biopharmaceutical and Biomedicine Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify growth opportunities.

Segmentation

  • By Biopharmaceutical Product Types
    • Monoclonal Antibodies (mAbs)
    • Vaccines
    • Recombinant Proteins
    • Gene and Cell Therapies
    • Nucleic Acid Therapeutics
    • Viral Vector-Based Therapies
    • Biosimilars
    • Blood and Blood Component Products
    • Biopharmaceutical Contract Manufacturing
  • By Therapeutic Areas
    • Oncology
    • Autoimmune Diseases
    • Infectious Diseases
    • Neurodegenerative Diseases
    • Rare Diseases (Orphan Drugs)
    • Cardiovascular Diseases
    • Gastrointestinal Disorders
    • Hematology
    • Dermatology
  • By Biopharmaceutical Companies
    • Pharmaceutical Companies
    • Biotechnology Startups
    • Contract Research Organizations (CROs)
    • Academic and Research Institutions
  • By Regulatory and Compliance
    • Regulatory Agencies
    • Good Manufacturing Practices (GMP)
    • Clinical Trials
    • Pharmacovigilance
  • By Market Trends
    • Personalized Medicine
    • Biopharmaceutical Innovation
    • Biosimilars and Biogenerics
    • Cell and Gene Therapies
    • Immunotherapy
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of the Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Biopharmaceutical and Biomedicine Market
2.1.1. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Product Types
2.1.2. Global Biopharmaceutical and Biomedicine Market, By Therapeutic Areas
2.1.3. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Companies
2.1.4. Global Biopharmaceutical and Biomedicine Market, By Regulatory and Compliance
2.1.5. Global Biopharmaceutical and Biomedicine Market, By Market Trends
2.1.6. Global Biopharmaceutical and Biomedicine Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Biopharmaceutical and Biomedicine Market Value, 2022-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Biopharmaceutical and Biomedicine Market Drivers
3.2.2. Biopharmaceutical and Biomedicine Market Restraints
3.2.3. Biopharmaceutical and Biomedicine Market Opportunities
3.2.4. Major Biopharmaceutical and Biomedicine Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Biopharmaceutical Product Types
3.5.2. Therapeutic Areas
3.5.3. Biopharmaceutical Companies
3.5.4. Regulatory and Compliance
3.5.5. Market Trends
3.5.6. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Biopharmaceutical and Biomedicine Market: Company Market Share, Value 2022
4.1.2. Global Biopharmaceutical and Biomedicine Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Biopharmaceutical and Biomedicine Market: Top 3 Company Market Share, Value 2022
4.2. Global Biopharmaceutical and Biomedicine Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Biopharmaceutical and Biomedicine Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Biopharmaceutical and Biomedicine Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Product Types
8.1. Global Biopharmaceutical and Biomedicine Market Overview, by Biopharmaceutical Product Types
8.1.1. Global Biopharmaceutical and Biomedicine Market Revenue Share, By Biopharmaceutical Product Types, 2022 Vs 2030 (in %)
8.2. Monoclonal Antibodies (mAbs)
8.2.1. Global Biopharmaceutical and Biomedicine Market, By Monoclonal Antibodies (mAbs), By Region, 2022-2030 (US$ Mn)
8.2.2. Market Dynamics for Monoclonal Antibodies (mAbs)
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Vaccines
8.3.1. Global Biopharmaceutical and Biomedicine Market, By Vaccines, By Region, 2022-2030 (US$ Mn)
8.3.2. Market Dynamics for Vaccines
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Recombinant Proteins
8.4.1. Global Biopharmaceutical and Biomedicine Market, By Recombinant Proteins, By Region, 2022-2030 (US$ Mn)
8.4.2. Market Dynamics for Recombinant Proteins
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Gene and Cell Therapies
8.5.1. Global Biopharmaceutical and Biomedicine Market, By Gene and Cell Therapies, By Region, 2022-2030 (US$ Mn)
8.5.2. Market Dynamics for Gene and Cell Therapies
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Nucleic Acid Therapeutics
8.6.1. Global Biopharmaceutical and Biomedicine Market, By Nucleic Acid Therapeutics, By Region, 2022-2030 (US$ Mn)
8.6.2. Market Dynamics for Nucleic Acid Therapeutics
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
8.7. Viral Vector-Based Therapies
8.7.1. Global Biopharmaceutical and Biomedicine Market, By Viral Vector-Based Therapies, By Region, 2022-2030 (US$ Mn)
8.7.2. Market Dynamics for Viral Vector-Based Therapies
8.7.2.1. Drivers
8.7.2.2. Restraints
8.7.2.3. Opportunities
8.7.2.4. Trends
8.8. Biosimilars
8.8.1. Global Biopharmaceutical and Biomedicine Market, By Biosimilars, By Region, 2022-2030 (US$ Mn)
8.8.2. Market Dynamics for Biosimilars
8.8.2.1. Drivers
8.8.2.2. Restraints
8.8.2.3. Opportunities
8.8.2.4. Trends
8.9. Blood and Blood Component Products
8.9.1. Global Biopharmaceutical and Biomedicine Market, By Blood and Blood Component Products, By Region, 2022-2030 (US$ Mn)
8.9.2. Market Dynamics for Blood and Blood Component Products
8.9.2.1. Drivers
8.9.2.2. Restraints
8.9.2.3. Opportunities
8.9.2.4. Trends
8.10. Biopharmaceutical Contract Manufacturing
8.10.1. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Contract Manufacturing, By Region, 2022-2030 (US$ Mn)
8.10.2. Market Dynamics for Biopharmaceutical Contract Manufacturing
8.10.2.1. Drivers
8.10.2.2. Restraints
8.10.2.3. Opportunities
8.10.2.4. Trends
9. Global Biopharmaceutical and Biomedicine Market, By Therapeutic Areas
9.1. Global Biopharmaceutical and Biomedicine Market Overview, by Therapeutic Areas
9.1.1. Global Biopharmaceutical and Biomedicine Market Revenue Share, By Therapeutic Areas, 2022 Vs 2030 (in %)
9.2. Oncology
9.2.1. Global Biopharmaceutical and Biomedicine Market, By Oncology, By Region, 2022-2030 (US$ Mn)
9.2.2. Market Dynamics for Oncology
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Autoimmune Diseases
9.3.1. Global Biopharmaceutical and Biomedicine Market, By Autoimmune Diseases, By Region, 2022-2030 (US$ Mn)
9.3.2. Market Dynamics for Autoimmune Diseases
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Infectious Diseases
9.4.1. Global Biopharmaceutical and Biomedicine Market, By Infectious Diseases, By Region, 2022-2030 (US$ Mn)
9.4.2. Market Dynamics for Infectious Diseases
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Neurodegenerative Diseases
9.5.1. Global Biopharmaceutical and Biomedicine Market, By Neurodegenerative Diseases, By Region, 2022-2030 (US$ Mn)
9.5.2. Market Dynamics for Neurodegenerative Diseases
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
9.6. Rare Diseases (Orphan Drugs)
9.6.1. Global Biopharmaceutical and Biomedicine Market, By Rare Diseases (Orphan Drugs), By Region, 2022-2030 (US$ Mn)
9.6.2. Market Dynamics for Rare Diseases (Orphan Drugs)
9.6.2.1. Drivers
9.6.2.2. Restraints
9.6.2.3. Opportunities
9.6.2.4. Trends
9.7. Cardiovascular Diseases
9.7.1. Global Biopharmaceutical and Biomedicine Market, By Cardiovascular Diseases, By Region, 2022-2030 (US$ Mn)
9.7.2. Market Dynamics for Cardiovascular Diseases
9.7.2.1. Drivers
9.7.2.2. Restraints
9.7.2.3. Opportunities
9.7.2.4. Trends
9.8. Gastrointestinal Disorders
9.8.1. Global Biopharmaceutical and Biomedicine Market, By Gastrointestinal Disorders, By Region, 2022-2030 (US$ Mn)
9.8.2. Market Dynamics for Gastrointestinal Disorders
9.8.2.1. Drivers
9.8.2.2. Restraints
9.8.2.3. Opportunities
9.8.2.4. Trends
9.9. Hematology
9.9.1. Global Biopharmaceutical and Biomedicine Market, By Hematology, By Region, 2022-2030 (US$ Mn)
9.9.2. Market Dynamics for Hematology
9.9.2.1. Drivers
9.9.2.2. Restraints
9.9.2.3. Opportunities
9.9.2.4. Trends
9.10. Dermatology
9.10.1. Global Biopharmaceutical and Biomedicine Market, By Dermatology, By Region, 2022-2030 (US$ Mn)
9.10.2. Market Dynamics for Dermatology
9.10.2.1. Drivers
9.10.2.2. Restraints
9.10.2.3. Opportunities
9.10.2.4. Trends
10. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Companies
10.1. Global Biopharmaceutical and Biomedicine Market Overview, by Biopharmaceutical Companies
10.1.1. Global Biopharmaceutical and Biomedicine Market Revenue Share, By Biopharmaceutical Companies, 2022 Vs 2030 (in %)
10.2. Pharmaceutical Companies
10.2.1. Global Biopharmaceutical and Biomedicine Market, By Pharmaceutical Companies, By Region, 2022-2030 (US$ Mn)
10.2.2. Market Dynamics for Pharmaceutical Companies
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Biotechnology Startups
10.3.1. Global Biopharmaceutical and Biomedicine Market, By Biotechnology Startups, By Region, 2022-2030 (US$ Mn)
10.3.2. Market Dynamics for Biotechnology Startups
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Contract Research Organizations (CROs)
10.4.1. Global Biopharmaceutical and Biomedicine Market, By Contract Research Organizations (CROs), By Region, 2022-2030 (US$ Mn)
10.4.2. Market Dynamics for Contract Research Organizations (CROs)
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Academic and Research Institutions
10.5.1. Global Biopharmaceutical and Biomedicine Market, By Academic and Research Institutions, By Region, 2022-2030 (US$ Mn)
10.5.2. Market Dynamics for Academic and Research Institutions
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
11. Global Biopharmaceutical and Biomedicine Market, By Regulatory and Compliance
11.1. Global Biopharmaceutical and Biomedicine Market Overview, by Regulatory and Compliance
11.1.1. Global Biopharmaceutical and Biomedicine Market Revenue Share, By Regulatory and Compliance, 2022 Vs 2030 (in %)
11.2. Regulatory Agencies
11.2.1. Global Biopharmaceutical and Biomedicine Market, By Regulatory Agencies, By Region, 2022-2030 (US$ Mn)
11.2.2. Market Dynamics for Regulatory Agencies
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Good Manufacturing Practices (GMP)
11.3.1. Global Biopharmaceutical and Biomedicine Market, By Good Manufacturing Practices (GMP), By Region, 2022-2030 (US$ Mn)
11.3.2. Market Dynamics for Good Manufacturing Practices (GMP)
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Clinical Trials
11.4.1. Global Biopharmaceutical and Biomedicine Market, By Clinical Trials, By Region, 2022-2030 (US$ Mn)
11.4.2. Market Dynamics for Clinical Trials
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
11.5. Pharmacovigilance
11.5.1. Global Biopharmaceutical and Biomedicine Market, By Pharmacovigilance, By Region, 2022-2030 (US$ Mn)
11.5.2. Market Dynamics for Pharmacovigilance
11.5.2.1. Drivers
11.5.2.2. Restraints
11.5.2.3. Opportunities
11.5.2.4. Trends
12. Global Biopharmaceutical and Biomedicine Market, By Market Trends
12.1. Global Biopharmaceutical and Biomedicine Market Overview, by Market Trends
12.1.1. Global Biopharmaceutical and Biomedicine Market Revenue Share, By Market Trends, 2022 Vs 2030 (in %)
12.2. Personalized Medicine
12.2.1. Global Biopharmaceutical and Biomedicine Market, By Personalized Medicine, By Region, 2022-2030 (US$ Mn)
12.2.2. Market Dynamics for Personalized Medicine
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Biopharmaceutical Innovation
12.3.1. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Innovation, By Region, 2022-2030 (US$ Mn)
12.3.2. Market Dynamics for Biopharmaceutical Innovation
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Biosimilars and Biogenerics
12.4.1. Global Biopharmaceutical and Biomedicine Market, By Biosimilars and Biogenerics, By Region, 2022-2030 (US$ Mn)
12.4.2. Market Dynamics for Biosimilars and Biogenerics
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
12.5. Cell and Gene Therapies
12.5.1. Global Biopharmaceutical and Biomedicine Market, By Cell and Gene Therapies, By Region, 2022-2030 (US$ Mn)
12.5.2. Market Dynamics for Cell and Gene Therapies
12.5.2.1. Drivers
12.5.2.2. Restraints
12.5.2.3. Opportunities
12.5.2.4. Trends
12.6. Immunotherapy
12.6.1. Global Biopharmaceutical and Biomedicine Market, By Immunotherapy, By Region, 2022-2030 (US$ Mn)
12.6.2. Market Dynamics for Immunotherapy
12.6.2.1. Drivers
12.6.2.2. Restraints
12.6.2.3. Opportunities
12.6.2.4. Trends
13. Global Biopharmaceutical and Biomedicine Market, By Region
13.1. Global Biopharmaceutical and Biomedicine Market Overview, by Region
13.1.1. Global Biopharmaceutical and Biomedicine Market, By Region, 2022 vs 2030 (in%)
13.2. Biopharmaceutical Product Types
13.2.1. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Product Types, 2022-2030 (US$ Mn)
13.3. Therapeutic Areas
13.3.1. Global Biopharmaceutical and Biomedicine Market, By Therapeutic Areas, 2022-2030 (US$ Mn)
13.4. Biopharmaceutical Companies
13.4.1. Global Biopharmaceutical and Biomedicine Market, By Biopharmaceutical Companies, 2022-2030 (US$ Mn)
13.5. Regulatory and Compliance
13.5.1. Global Biopharmaceutical and Biomedicine Market, By Regulatory and Compliance, 2022-2030 (US$ Mn)
13.6. Market Trends
13.6.1. Global Biopharmaceutical and Biomedicine Market, By Market Trends, 2022-2030 (US$ Mn)
14. North America Biopharmaceutical and Biomedicine Market Analysis
14.1. Overview
14.1.1. Market Dynamics for North America
14.1.1.1. Drivers
14.1.1.2. Restraints
14.1.1.3. Opportunities
14.1.1.4. Trends
14.2. North America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2030(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. North America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2030(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. North America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2030(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. North America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2030(US$ Mn)
14.5.1. Overview
14.5.2. SRC Analysis
14.6. North America Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2030(US$ Mn)
14.6.1. Overview
14.6.2. SRC Analysis
14.7. North America Biopharmaceutical and Biomedicine Market, by Country, 2022-2030 (US$ Mn)
14.7.1. North America Biopharmaceutical and Biomedicine Market, by Country, 2022 Vs 2030 (in%)
14.7.2. U.S.
14.7.3. Canada
14.7.4. Mexico
15. Europe Biopharmaceutical and Biomedicine Market Analysis
15.1. Overview
15.1.1. Market Dynamics for Europe
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Europe Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. Europe Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2030(US$ Mn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. Europe Biopharmaceutical and Biomedicine Market, by Country, 2022-2030 (US$ Mn)
15.7.1. Europe Biopharmaceutical and Biomedicine Market, by Country, 2022 Vs 2030 (in%)
15.7.2. UK
15.7.3. France
15.7.4. Germany
15.7.5. Italy
15.7.6. Spain
15.7.7. Benelux
15.7.8. Russia
15.7.9. Rest of Europe
16. Asia Pacific Biopharmaceutical and Biomedicine Market Analysis
16.1. Overview
16.1.1. Market Dynamics for Asia Pacific
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Asia Pacific Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Asia Pacific Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Asia Pacific Biopharmaceutical and Biomedicine Market, by Country, 2022-2030 (US$ Mn)
16.7.1. Asia Pacific Biopharmaceutical and Biomedicine Market, by Country, 2022 Vs 2030 (in%)
16.7.2. China
16.7.3. Japan
16.7.4. India
16.7.5. South Korea
16.7.6. South East Asia
16.7.7. Rest of Asia Pacific
17. Latin America Biopharmaceutical and Biomedicine Market Analysis
17.1. Overview
17.1.1. Market Dynamics for Latin America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Latin America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Latin America Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Latin America Biopharmaceutical and Biomedicine Market, by Country, 2022-2030 (US$ Mn)
17.7.1. Latin America Biopharmaceutical and Biomedicine Market, by Country, 2022 Vs 2030 (in%)
17.7.2. Brazil
17.7.3. Argentina
17.7.4. Rest of Latin America
18. Middle East Biopharmaceutical and Biomedicine Market Analysis
18.1. Overview
18.1.1. Market Dynamics for Middle East
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Middle East Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Middle East Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Middle East Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Middle East Biopharmaceutical and Biomedicine Market, by Country, 2022-2030 (US$ Mn)
18.7.1. Middle East Biopharmaceutical and Biomedicine Market, by Country, 2022 Vs 2030 (in%)
18.7.2. UAE
18.7.3. Saudi Arabia
18.7.4. Rest of Middle East
19. Africa Biopharmaceutical and Biomedicine Market Analysis
19.1. Overview
19.1.1. Market Dynamics for Africa
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Africa Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Africa Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Africa Biopharmaceutical and Biomedicine Market, by Country, 2022-2030 (US$ Mn)
19.7.1. Africa Biopharmaceutical and Biomedicine Market, by Country, 2022 Vs 2030 (in%)
19.7.2. South Africa
19.7.3. Egypt
19.7.4. Rest of Africa
20. Company profiles
20.1. Thermo Fisher Scientific
20.1.1. Company Overview
20.1.2. Products/Services Portfolio
20.1.3. Geographical Presence
20.1.4. SWOT Analysis
20.1.5. Financial Summary
20.1.5.1. Market Revenue and Net Profit (2019-2022)
20.1.5.2. Business Segment Revenue Analysis
20.1.5.3. Geographical Revenue Analysis
20.2. Merck KGaA
20.3. Takara Bio
20.4. Agilent Technologies
20.5. Oxford Expression Technologies
20.6. Promega Corporation
20.7. Qiagen N.V.
20.8. Bio-Rad Laboratories
20.9. New England Biolabs
20.10. Genscript Biotech Corporation
20.11. Syngene International Limited
20.12. Sartorius AG
20.13. Aragen Bioscience
20.14. Vivopure
20.15. Creative Biogene
20.16. Absolute Antibody
20.17. Rockland Immunochemicals
20.18. Protein Technologies Inc.
20.19. Proteogenix
20.20. Virovek
20.21. Others
21. Research Methodology
21.1. Research Methodology
21.2. Phase I – Secondary Research
21.3. Phase II – Data Modelling
21.3.1. Company Share Analysis Model
21.3.2. Revenue Based Modelling
21.4. Phase III – Primary Research
21.5. Research Limitations
21.5.1. Assumptions

List of Figures
FIG. 1 Global Biopharmaceutical and Biomedicine Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Biopharmaceutical and Biomedicine Market Segmentation
FIG. 4 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2022 (US$ Mn)
FIG. 5 Global Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2022 (US$ Mn)
FIG. 6 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2022 (US$ Mn)
FIG. 7 Global Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2022 (US$ Mn)
FIG. 8 Global Biopharmaceutical and Biomedicine Market, by Market Trends, 2022 (US$ Mn)
FIG. 9 Global Biopharmaceutical and Biomedicine Market, by Geography, 2022 (US$ Mn)
FIG. 10 Attractive Investment Proposition, by Biopharmaceutical Product Types, 2022
FIG. 11 Attractive Investment Proposition, by Therapeutic Areas, 2022
FIG. 12 Attractive Investment Proposition, by Biopharmaceutical Companies, 2022
FIG. 13 Attractive Investment Proposition, by Regulatory and Compliance, 2022
FIG. 14 Attractive Investment Proposition, by Market Trends, 2022
FIG. 15 Attractive Investment Proposition, by Geography, 2022
FIG. 16 Global Market Share Analysis of Key Biopharmaceutical and Biomedicine Market Manufacturers, 2022
FIG. 17 Global Market Positioning of Key Biopharmaceutical and Biomedicine Market Manufacturers, 2022
FIG. 18 Global Biopharmaceutical and Biomedicine Market Value Contribution, By Biopharmaceutical Product Types, 2022 & 2030 (Value %)
FIG. 19 Global Biopharmaceutical and Biomedicine Market, by Monoclonal Antibodies (mAbs), Value, 2022-2030 (US$ Mn)
FIG. 20 Global Biopharmaceutical and Biomedicine Market, by Vaccines, Value, 2022-2030 (US$ Mn)
FIG. 21 Global Biopharmaceutical and Biomedicine Market, by Recombinant Proteins, Value, 2022-2030 (US$ Mn)
FIG. 22 Global Biopharmaceutical and Biomedicine Market, by Gene and Cell Therapies, Value, 2022-2030 (US$ Mn)
FIG. 23 Global Biopharmaceutical and Biomedicine Market, by Nucleic Acid Therapeutics, Value, 2022-2030 (US$ Mn)
FIG. 24 Global Biopharmaceutical and Biomedicine Market, by Viral Vector-Based Therapies, Value, 2022-2030 (US$ Mn)
FIG. 25 Global Biopharmaceutical and Biomedicine Market, by Biosimilars, Value, 2022-2030 (US$ Mn)
FIG. 26 Global Biopharmaceutical and Biomedicine Market, by Blood and Blood Component Products, Value, 2022-2030 (US$ Mn)
FIG. 27 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Contract Manufacturing, Value, 2022-2030 (US$ Mn)
FIG. 28 Global Biopharmaceutical and Biomedicine Market Value Contribution, By Therapeutic Areas, 2022 & 2030 (Value %)
FIG. 29 Global Biopharmaceutical and Biomedicine Market, by Oncology, Value, 2022-2030 (US$ Mn)
FIG. 30 Global Biopharmaceutical and Biomedicine Market, by Autoimmune Diseases, Value, 2022-2030 (US$ Mn)
FIG. 31 Global Biopharmaceutical and Biomedicine Market, by Infectious Diseases, Value, 2022-2030 (US$ Mn)
FIG. 32 Global Biopharmaceutical and Biomedicine Market, by Neurodegenerative Diseases, Value, 2022-2030 (US$ Mn)
FIG. 33 Global Biopharmaceutical and Biomedicine Market, by Rare Diseases (Orphan Drugs), Value, 2022-2030 (US$ Mn)
FIG. 34 Global Biopharmaceutical and Biomedicine Market, by Cardiovascular Diseases, Value, 2022-2030 (US$ Mn)
FIG. 35 Global Biopharmaceutical and Biomedicine Market, by Gastrointestinal Disorders, Value, 2022-2030 (US$ Mn)
FIG. 36 Global Biopharmaceutical and Biomedicine Market, by Hematology, Value, 2022-2030 (US$ Mn)
FIG. 37 Global Biopharmaceutical and Biomedicine Market, by Dermatology, Value, 2022-2030 (US$ Mn)
FIG. 38 Global Biopharmaceutical and Biomedicine Market Value Contribution, By Biopharmaceutical Companies, 2022 & 2030 (Value %)
FIG. 39 Global Biopharmaceutical and Biomedicine Market, by Pharmaceutical Companies, Value, 2022-2030 (US$ Mn)
FIG. 40 Global Biopharmaceutical and Biomedicine Market, by Biotechnology Startups, Value, 2022-2030 (US$ Mn)
FIG. 41 Global Biopharmaceutical and Biomedicine Market, by Contract Research Organizations (CROs), Value, 2022-2030 (US$ Mn)
FIG. 42 Global Biopharmaceutical and Biomedicine Market, by Academic and Research Institutions, Value, 2022-2030 (US$ Mn)
FIG. 43 Global Biopharmaceutical and Biomedicine Market Value Contribution, By Regulatory and Compliance, 2022 & 2030 (Value %)
FIG. 44 Global Biopharmaceutical and Biomedicine Market, by Regulatory Agencies, Value, 2022-2030 (US$ Mn)
FIG. 45 Global Biopharmaceutical and Biomedicine Market, by Good Manufacturing Practices (GMP), Value, 2022-2030 (US$ Mn)
FIG. 46 Global Biopharmaceutical and Biomedicine Market, by Clinical Trials, Value, 2022-2030 (US$ Mn)
FIG. 47 Global Biopharmaceutical and Biomedicine Market, by Pharmacovigilance, Value, 2022-2030 (US$ Mn)
FIG. 48 Global Biopharmaceutical and Biomedicine Market Value Contribution, By Market Trends, 2022 & 2030 (Value %)
FIG. 49 Global Biopharmaceutical and Biomedicine Market, by Personalized Medicine, Value, 2022-2030 (US$ Mn)
FIG. 50 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Innovation, Value, 2022-2030 (US$ Mn)
FIG. 51 Global Biopharmaceutical and Biomedicine Market, by Biosimilars and Biogenerics, Value, 2022-2030 (US$ Mn)
FIG. 52 Global Biopharmaceutical and Biomedicine Market, by Cell and Gene Therapies, Value, 2022-2030 (US$ Mn)
FIG. 53 Global Biopharmaceutical and Biomedicine Market, by Immunotherapy, Value, 2022-2030 (US$ Mn)
FIG. 54 North America Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 55 U.S. Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 56 Canada Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 57 Mexico Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 58 Europe Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 59 Germany Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 60 France Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 61 U.K. Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 62 Italy Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 63 Spain Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 64 Benelux Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 65 Russia Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 66 Rest of Europe Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 67 Asia Pacific Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 68 China Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 69 Japan Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 70 India Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 71 South Korea Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 72 South-East Asia Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 73 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 74 Latin America Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 75 Brazil Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 76 Argentina Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 77 Rest of Latin America Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 78 Middle East Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 79 UAE Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 80 Saudi Arabia Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 81 Rest of Middle East Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 82 Africa Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 83 South Africa Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 84 Egypt Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)
FIG. 85 Rest of Africa Biopharmaceutical and Biomedicine Market, 2022-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Biopharmaceutical and Biomedicine Market
TABLE 2 Global Biopharmaceutical and Biomedicine Market: Market Drivers Impact Analysis
TABLE 3 Global Biopharmaceutical and Biomedicine Market: Market Restraints Impact Analysis
TABLE 4 Global Biopharmaceutical and Biomedicine Market, by Competitive Benchmarking, 2022
TABLE 5 Global Biopharmaceutical and Biomedicine Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Biopharmaceutical and Biomedicine Market, by Key Strategies Analysis, 2022
TABLE 7 Global Biopharmaceutical and Biomedicine Market, by Monoclonal Antibodies (mAbs), By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Biopharmaceutical and Biomedicine Market, by Monoclonal Antibodies (mAbs), By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Biopharmaceutical and Biomedicine Market, by Vaccines, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Biopharmaceutical and Biomedicine Market, by Vaccines, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Biopharmaceutical and Biomedicine Market, by Recombinant Proteins, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Biopharmaceutical and Biomedicine Market, by Recombinant Proteins, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Biopharmaceutical and Biomedicine Market, by Gene and Cell Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Biopharmaceutical and Biomedicine Market, by Gene and Cell Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Biopharmaceutical and Biomedicine Market, by Nucleic Acid Therapeutics, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Biopharmaceutical and Biomedicine Market, by Nucleic Acid Therapeutics, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Biopharmaceutical and Biomedicine Market, by Viral Vector-Based Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Biopharmaceutical and Biomedicine Market, by Viral Vector-Based Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Biopharmaceutical and Biomedicine Market, by Biosimilars, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Biopharmaceutical and Biomedicine Market, by Biosimilars, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Biopharmaceutical and Biomedicine Market, by Blood and Blood Component Products, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Biopharmaceutical and Biomedicine Market, by Blood and Blood Component Products, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Contract Manufacturing, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Contract Manufacturing, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Biopharmaceutical and Biomedicine Market, by Oncology, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Biopharmaceutical and Biomedicine Market, by Oncology, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Biopharmaceutical and Biomedicine Market, by Autoimmune Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Biopharmaceutical and Biomedicine Market, by Autoimmune Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Biopharmaceutical and Biomedicine Market, by Infectious Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Biopharmaceutical and Biomedicine Market, by Infectious Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Biopharmaceutical and Biomedicine Market, by Neurodegenerative Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Biopharmaceutical and Biomedicine Market, by Neurodegenerative Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Biopharmaceutical and Biomedicine Market, by Rare Diseases (Orphan Drugs), By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Biopharmaceutical and Biomedicine Market, by Rare Diseases (Orphan Drugs), By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Biopharmaceutical and Biomedicine Market, by Cardiovascular Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Biopharmaceutical and Biomedicine Market, by Cardiovascular Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Biopharmaceutical and Biomedicine Market, by Gastrointestinal Disorders, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Biopharmaceutical and Biomedicine Market, by Gastrointestinal Disorders, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Biopharmaceutical and Biomedicine Market, by Hematology, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Biopharmaceutical and Biomedicine Market, by Hematology, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Biopharmaceutical and Biomedicine Market, by Dermatology, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Biopharmaceutical and Biomedicine Market, by Dermatology, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Biopharmaceutical and Biomedicine Market, by Pharmaceutical Companies, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global Biopharmaceutical and Biomedicine Market, by Pharmaceutical Companies, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global Biopharmaceutical and Biomedicine Market, by Biotechnology Startups, By Region, 2017-2022 (US$ Mn)
TABLE 46 Global Biopharmaceutical and Biomedicine Market, by Biotechnology Startups, By Region, 2023-2030 (US$ Mn)
TABLE 47 Global Biopharmaceutical and Biomedicine Market, by Contract Research Organizations (CROs), By Region, 2017-2022 (US$ Mn)
TABLE 48 Global Biopharmaceutical and Biomedicine Market, by Contract Research Organizations (CROs), By Region, 2023-2030 (US$ Mn)
TABLE 49 Global Biopharmaceutical and Biomedicine Market, by Academic and Research Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 50 Global Biopharmaceutical and Biomedicine Market, by Academic and Research Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 51 Global Biopharmaceutical and Biomedicine Market, by Regulatory Agencies, By Region, 2017-2022 (US$ Mn)
TABLE 52 Global Biopharmaceutical and Biomedicine Market, by Regulatory Agencies, By Region, 2023-2030 (US$ Mn)
TABLE 53 Global Biopharmaceutical and Biomedicine Market, by Good Manufacturing Practices (GMP), By Region, 2017-2022 (US$ Mn)
TABLE 54 Global Biopharmaceutical and Biomedicine Market, by Good Manufacturing Practices (GMP), By Region, 2023-2030 (US$ Mn)
TABLE 55 Global Biopharmaceutical and Biomedicine Market, by Clinical Trials, By Region, 2017-2022 (US$ Mn)
TABLE 56 Global Biopharmaceutical and Biomedicine Market, by Clinical Trials, By Region, 2023-2030 (US$ Mn)
TABLE 57 Global Biopharmaceutical and Biomedicine Market, by Pharmacovigilance, By Region, 2017-2022 (US$ Mn)
TABLE 58 Global Biopharmaceutical and Biomedicine Market, by Pharmacovigilance, By Region, 2023-2030 (US$ Mn)
TABLE 59 Global Biopharmaceutical and Biomedicine Market, by Personalized Medicine, By Region, 2017-2022 (US$ Mn)
TABLE 60 Global Biopharmaceutical and Biomedicine Market, by Personalized Medicine, By Region, 2023-2030 (US$ Mn)
TABLE 61 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Innovation, By Region, 2017-2022 (US$ Mn)
TABLE 62 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Innovation, By Region, 2023-2030 (US$ Mn)
TABLE 63 Global Biopharmaceutical and Biomedicine Market, by Biosimilars and Biogenerics, By Region, 2017-2022 (US$ Mn)
TABLE 64 Global Biopharmaceutical and Biomedicine Market, by Biosimilars and Biogenerics, By Region, 2023-2030 (US$ Mn)
TABLE 65 Global Biopharmaceutical and Biomedicine Market, by Cell and Gene Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 66 Global Biopharmaceutical and Biomedicine Market, by Cell and Gene Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 67 Global Biopharmaceutical and Biomedicine Market, by Immunotherapy, By Region, 2017-2022 (US$ Mn)
TABLE 68 Global Biopharmaceutical and Biomedicine Market, by Immunotherapy, By Region, 2023-2030 (US$ Mn)
TABLE 69 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 70 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 71 Global Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 72 Global Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 73 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 74 Global Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 75 Global Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 76 Global Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 77 Global Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 78 Global Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 79 Global Biopharmaceutical and Biomedicine Market, by Region, 2017-2022 (US$ Mn)
TABLE 80 Global Biopharmaceutical and Biomedicine Market, by Region, 2023-2030 (US$ Mn)
TABLE 81 North America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 82 North America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 83 North America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 84 North America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 85 North America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 86 North America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 87 North America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 88 North America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 89 North America Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 90 North America Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 91 North America Biopharmaceutical and Biomedicine Market, by Country, 2017-2022 (US$ Mn)
TABLE 92 North America Biopharmaceutical and Biomedicine Market, by Country, 2023-2030 (US$ Mn)
TABLE 93 United States Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 94 United States Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 95 United States Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 96 United States Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 97 United States Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 98 United States Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 99 United States Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 100 United States Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 101 United States Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 102 United States Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 103 Canada Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 104 Canada Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 105 Canada Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 106 Canada Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 107 Canada Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 108 Canada Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 109 Canada Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 110 Canada Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 111 Canada Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 112 Canada Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 113 Mexico Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 114 Mexico Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 115 Mexico Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 116 Mexico Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 117 Mexico Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 118 Mexico Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 119 Mexico Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 120 Mexico Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 121 Mexico Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 122 Mexico Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 123 Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 124 Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 125 Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 126 Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 127 Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 128 Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 129 Europe Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 130 Europe Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 131 Europe Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 132 Europe Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 133 Europe Biopharmaceutical and Biomedicine Market, by Country, 2017-2022 (US$ Mn)
TABLE 134 Europe Biopharmaceutical and Biomedicine Market, by Country, 2023-2030 (US$ Mn)
TABLE 135 Germany Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 136 Germany Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 137 Germany Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 138 Germany Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 139 Germany Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 140 Germany Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 141 Germany Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 142 Germany Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 143 Germany Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 144 Germany Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 145 France Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 146 France Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 147 France Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 148 France Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 149 France Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 150 France Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 151 France Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 152 France Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 153 France Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 154 France Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 155 United Kingdom Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 156 United Kingdom Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 157 United Kingdom Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 158 United Kingdom Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 159 United Kingdom Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 160 United Kingdom Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 161 United Kingdom Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 162 United Kingdom Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 163 United Kingdom Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 164 United Kingdom Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 165 Italy Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 166 Italy Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 167 Italy Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 168 Italy Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 169 Italy Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 170 Italy Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 171 Italy Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 172 Italy Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 173 Italy Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 174 Italy Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 175 Spain Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 176 Spain Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 177 Spain Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 178 Spain Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 179 Spain Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 180 Spain Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 181 Spain Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 182 Spain Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 183 Spain Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 184 Spain Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 185 Benelux Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 186 Benelux Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 187 Benelux Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 188 Benelux Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 189 Benelux Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 190 Benelux Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 191 Benelux Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 192 Benelux Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 193 Benelux Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 194 Benelux Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 195 Russia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 196 Russia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 197 Russia Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 198 Russia Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 199 Russia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 200 Russia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 201 Russia Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 202 Russia Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 203 Russia Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 204 Russia Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 205 Rest of Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 206 Rest of Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 207 Rest of Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 208 Rest of Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 209 Rest of Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 210 Rest of Europe Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 211 Rest of Europe Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 212 Rest of Europe Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 213 Rest of Europe Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 214 Rest of Europe Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 215 Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 216 Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 217 Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 218 Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 219 Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 220 Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 221 Asia Pacific Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 222 Asia Pacific Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 223 Asia Pacific Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 224 Asia Pacific Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 225 China Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 226 China Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 227 China Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 228 China Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 229 China Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 230 China Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 231 China Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 232 China Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 233 China Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 234 China Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 235 Japan Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 236 Japan Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 237 Japan Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 238 Japan Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 239 Japan Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 240 Japan Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 241 Japan Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 242 Japan Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 243 Japan Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 244 Japan Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 245 India Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 246 India Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 247 India Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 248 India Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 249 India Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 250 India Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 251 India Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 252 India Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 253 India Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 254 India Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 255 South Korea Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 256 South Korea Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 257 South Korea Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 258 South Korea Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 259 South Korea Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 260 South Korea Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 261 South Korea Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 262 South Korea Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 263 South Korea Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 264 South Korea Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 265 South-East Asia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 266 South-East Asia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 267 South-East Asia Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 268 South-East Asia Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 269 South-East Asia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 270 South-East Asia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 271 South-East Asia Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 272 South-East Asia Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 273 South-East Asia Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 274 South-East Asia Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 275 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 276 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 277 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 278 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 279 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 280 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 281 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 282 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 283 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 284 Rest of Asia Pacific Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 285 Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 286 Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 287 Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 288 Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 289 Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 290 Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 291 Latin America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 292 Latin America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 293 Latin America Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 294 Latin America Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 295 Brazil Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 296 Brazil Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 297 Brazil Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 298 Brazil Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 299 Brazil Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 300 Brazil Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 301 Brazil Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 302 Brazil Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 303 Brazil Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 304 Brazil Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 305 Argentina Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 306 Argentina Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 307 Argentina Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 308 Argentina Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 309 Argentina Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 310 Argentina Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 311 Argentina Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 312 Argentina Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 313 Argentina Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 314 Argentina Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 315 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 316 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 317 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 318 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 319 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 320 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 321 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 322 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 323 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 324 Rest of Latin America Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 325 Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 326 Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 327 Middle East Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 328 Middle East Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 329 Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 330 Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 331 Middle East Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 332 Middle East Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 333 Middle East Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 334 Middle East Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 335 UAE Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 336 UAE Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 337 UAE Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 338 UAE Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 339 UAE Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 340 UAE Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 341 UAE Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 342 UAE Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 343 UAE Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 344 UAE Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 345 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 346 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 347 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 348 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 349 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 350 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 351 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 352 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 353 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 354 Saudi Arabia Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 355 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 356 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 357 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 358 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 359 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 360 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 361 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 362 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 363 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 364 Rest of Middle East Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 365 Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 366 Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 367 Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 368 Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 369 Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 370 Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 371 Africa Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 372 Africa Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 373 Africa Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 374 Africa Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 375 South Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 376 South Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 377 South Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 378 South Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 379 South Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 380 South Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 381 South Africa Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 382 South Africa Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 383 South Africa Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 384 South Africa Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 385 Egypt Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 386 Egypt Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 387 Egypt Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 388 Egypt Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 389 Egypt Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 390 Egypt Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 391 Egypt Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 392 Egypt Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 393 Egypt Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 394 Egypt Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 395 Rest of Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2017-2022 (US$ Mn)
TABLE 396 Rest of Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Product Types, 2023-2030 (US$ Mn)
TABLE 397 Rest of Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 398 Rest of Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 399 Rest of Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2017-2022 (US$ Mn)
TABLE 400 Rest of Africa Biopharmaceutical and Biomedicine Market, by Biopharmaceutical Companies, 2023-2030 (US$ Mn)
TABLE 401 Rest of Africa Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2017-2022 (US$ Mn)
TABLE 402 Rest of Africa Biopharmaceutical and Biomedicine Market, by Regulatory and Compliance, 2023-2030 (US$ Mn)
TABLE 403 Rest of Africa Biopharmaceutical and Biomedicine Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 404 Rest of Africa Biopharmaceutical and Biomedicine Market, by Market Trends, 2023-2030 (US$ Mn)

How big is the global market for biopharmaceutical and biomedicine right now?

In 2022, the market for biopharmaceutical and biomedicine was estimated to be worth USD 545848.5 million.

What is the biopharmaceutical and biomedicine market’s anticipated growth rate from 2023 to 2030?

The market for biopharmaceutical and biomedicine is anticipated to increase at a CAGR of 9.80% from 2023 to 2030, reaching USD 1153163.37 million in 2030.

Which market category is in the lead for the biopharmaceutical product types?

Gene and cell therapies are the most popular biopharmaceutical product types category.

Which segment is leading the market in terms of therapeutic areas?

Oncology, by therapeutic areas, is the notable segment.

Which biopharmaceutical companies segment is estimated to have the highest CAGR throughout the forecast period?

During the projection period, the pharmaceutical companies category is anticipated to exhibit the highest CAGR.

Qatar Dental Care Market

Published:
Report ID: 30608

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Hepatic Encephalopathy Market

Published:
Report ID: 33664

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Guidewires Market

Published:
Report ID: 6790

3D Printing for Personalized Healthcare Market

Published:
Report ID: 33603

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

In Vitro Diagnostic (IVD) Kit Market

Published:
Report ID: 33580

North America Medical Headgears Market

Published:
Report ID: 33554

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN